Table 4.
Spearman Correlation Analysis Between IBI and Clinical Parameters
| r | p value | |
|---|---|---|
| Sex, female (%) | −0.075 | <0.001 |
| Age(years) | 0.161 | <0.001 |
| BMI (kg/m2) | 0.077 | <0.001 |
| Smoking | 0.073 | <0.001 |
| Alcohol consumption | 0.037 | 0.037 |
| Diabetes | 0.013 | 0.446 |
| CVD | 0.063 | <0.001 |
| Systolic pressure (mmHg) | 0.07 | <0.001 |
| Diastolic pressure (mmHg) | 0.006 | 0.719 |
| Hemoglobin (g/L) | −0.06 | 0.001 |
| Albumin (g/L) | −0.107 | <0.001 |
| Calcium (mmol/L) | −0.08 | <0.001 |
| Phosphorus (mmol/L) | −0.029 | 0.103 |
| Intact Parathyroid hormone (pg/mL) | −0.033 | 0.063 |
| Cholesterol (mmol/L) | −0.028 | 0.109 |
| Triglyceride (mmol/L) | 0.035 | 0.047 |
| eGFR (mL/min/1.73m2) | 0.023 | 0.19 |
| Kt/V | −0.024 | 0.197 |
| CCB, n (%) | 0.006 | 0.731 |
| ACEI, n (%) | −0.004 | 0.838 |
| ARB, n (%) | −0.021 | 0.235 |
| β-blocker, n (%) | −0.015 | 0.386 |
| ɑ-blocker, n(%) | −0.026 | 0.142 |
| Diuretic, n(%) | 0.003 | 0.85 |
| Aspirin, n (%) | 0.002 | 0.912 |
Abbreviations: BMI, body mass index; CVD, cardiovascular disease; eGFR, estimated glomerular; Kt/V, K dialyzer clearance of urea; CCB, calcium channel blocker; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker.